These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8978190)

  • 21. Risk group-based management of differentiated thyroid carcinoma.
    Kuriakose MA; Hicks WL; Loree TR; Yee H
    J R Coll Surg Edinb; 2001 Aug; 46(4):216-23. PubMed ID: 11523714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary thyroid microcarcinoma: clinical study and prognosis.
    Rodriguez JM; Moreno A; Parrilla P; Sola J; Soria T; Tebar FJ; Aranda F
    Eur J Surg; 1997 Apr; 163(4):255-9. PubMed ID: 9161822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary management of papillary carcinoma of the thyroid gland.
    Rosenbaum MA; McHenry CR
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
    Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
    Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ; Torlantano M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
    Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
    Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
    Włoch J; Czarniecka A; Turska M; Wilgus J
    Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of papillary microcarcinoma of the thyroid.
    Haas SN
    S D Med; 2006 Oct; 59(10):425-7. PubMed ID: 17124919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
    Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
    Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence after treatment of micropapillary thyroid cancer.
    Ross DS; Litofsky D; Ain KB; Bigos T; Brierley JD; Cooper DS; Haugen BR; Jonklaas J; Ladenson PW; Magner J; Robbins J; Skarulis MC; Steward DL; Maxon HR; Sherman SI
    Thyroid; 2009 Oct; 19(10):1043-8. PubMed ID: 19772419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Total thyroidectomy of choice in papillary microcarcinoma].
    Pisello F; Geraci G; Sciumè C; Li Volsi F; Modica G
    G Chir; 2007; 28(1-2):13-9. PubMed ID: 17313727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of invasive and advanced thyroid cancer.
    Favia G; Iacobone M; Zanella S; Ciarleglio FA
    Minerva Endocrinol; 2009 Mar; 34(1):37-55. PubMed ID: 19209127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis.
    Lin KD; Lin JD; Huang MJ; Huang HS; Jeng LB; Chao TC; Ho YS
    Int Surg; 1997; 82(4):378-81. PubMed ID: 9412835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modern aspects of diagnostics and treatment of microcarcinomas of the thyroid gland].
    Sedov VM; Khmelevskaia VA
    Vestn Khir Im I I Grek; 2007; 166(1):112-6. PubMed ID: 17672122
    [No Abstract]   [Full Text] [Related]  

  • 39. [Non-incidental papillary microcarcinomas of the thyroid].
    Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
    Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.